Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor (PREMAPESSAIRE)
Primary Purpose
Preterm Birth
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Silicone pessary
Sponsored by
About this trial
This is an interventional treatment trial for Preterm Birth focused on measuring Preterm Birth, pessary, threatened preterm labor
Eligibility Criteria
Inclusion Criteria:
- Minimal age of 18 years
- Informed consent
- Confirmation of dating of pregnancy by first trimester echography.
- Episode of threatened preterm labour
- Singleton between 24 and 34 weeks of gestation
- Cervical length ≤20mm in cervimetry
- Pulmonary maturation completed
- ≤6 contractions by hour after 24 hours of tocolysis.
Exclusion Criteria:
- Major fetal abnormalities (requiring surgery or leading to infant death or severe handicap)
- Spontaneous rupture of membranes at the time of randomization
- Cervical cerclage in situ
- Uterus malformations
- Antecedent of conisation
- Active vaginal bleeding, placenta previa
- Intra-amniotic infection
- Hydramnios
- Maternal chronic pathology (hypertension, diabetes)
- Anomaly of breathing foetal rate
Sites / Locations
- Chu Saint-Etienne
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Pessary
Control
Arm Description
Silicone pessary is associated with standard care Silicone pessary is used between 24 weeks of pregnancy and up to 6 weeks after the date of the term (maximum 6 months)
Standard care only, No silicone pessary will be placed in the vagina.
Outcomes
Primary Outcome Measures
Number of spontaneous delivery
Comparison of the number of spontaneous delivery before 37 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Secondary Outcome Measures
Number of spontaneous delivery
Comparison of the number of spontaneous delivery before 34 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Number of spontaneous delivery
Comparison of the number of spontaneous delivery before 28 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Number of admission for preterm labor
Comparison of the number of admission for preterm labor from date of randomization until the date of the delivery between the 2 groups.
Number of fetal-neonatal death
Number of fetal-neonatal death at delivery
Number of birth death
Number of birth death at delivery until 6 weeks after the date of term
Number of patients with neonatal morbidity
Number of patient with neonatal morbidity at delivery until 6 weeks after the date of term
Number of patients with increase of vaginal discharge
Comparison of the number of patients with increase of vaginal discharge from date of randomization until the date of the delivery between the 2 groups of the study.
Number of patients with spontaneous pessary ejection
Comparison of the number of patients with pessary ejection from date of randomization until the date of the delivery between the 2 groups of the study.
Number of patients with discomfort
Comparison of the number of patients with discomfort from date of randomization until the date of the delivery between the 2 groups of the study. The discomfort is measure by a standardized questionnaire.
number of day between resolutive threatened preterm labor and delivery
Comparison of number of day between the two groups of the study
Full Information
NCT ID
NCT02484820
First Posted
June 17, 2015
Last Updated
May 23, 2023
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
1. Study Identification
Unique Protocol Identification Number
NCT02484820
Brief Title
Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor
Acronym
PREMAPESSAIRE
Official Title
PREMAPESSAIRE: Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor: a Prospective, Randomized Monocentric Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
December 1, 2015 (Actual)
Primary Completion Date
October 8, 2022 (Actual)
Study Completion Date
January 31, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In France, threatened preterm labour concerns 6.5% of pregnancies and is associated with a premature birth in 25.4% of cases.
After 48 hours effective tocolysis, patients do not receive any further treatment while their risk of premature birth has risen from 6.5% to 25%.
A pessary is a silicone ring encircling the cervix. It was initially used as medical treatment of genital prolapse but studies were also conducted for pregnant women in 2 high-risk premature birth situations: cervical incompetence and twin pregnancies.
The multicenter PECEP trial conducted by Goya and al. in asymptomatic short cervix patients between 18 and 22 weeks of gestation showed a significant reduction of premature birth before 34 and 37 weeks of gestation. Thereby, the investigator assume that use of pessaries in patients presenting a resolutive threatened preterm labor will also be effective.
To evaluate this hypothesis, the investigator designed a randomized prospective single-center open clinical trial comparing pessary associated with standard care (1st group) versus standard care only (2nd group) in patients experiencing an episode of resolutive threatened preterm labor.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth
Keywords
Preterm Birth, pessary, threatened preterm labor
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
168 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pessary
Arm Type
Experimental
Arm Description
Silicone pessary is associated with standard care Silicone pessary is used between 24 weeks of pregnancy and up to 6 weeks after the date of the term (maximum 6 months)
Arm Title
Control
Arm Type
No Intervention
Arm Description
Standard care only, No silicone pessary will be placed in the vagina.
Intervention Type
Device
Intervention Name(s)
Silicone pessary
Intervention Description
Silicone pessary is used between 24 weeks of pregnancy and up to 6 weeks after the date of the term (maximum 6 months)
Primary Outcome Measure Information:
Title
Number of spontaneous delivery
Description
Comparison of the number of spontaneous delivery before 37 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Time Frame
37 weeks of gestation
Secondary Outcome Measure Information:
Title
Number of spontaneous delivery
Description
Comparison of the number of spontaneous delivery before 34 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Time Frame
34 weeks of gestation
Title
Number of spontaneous delivery
Description
Comparison of the number of spontaneous delivery before 28 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.
Time Frame
28 weeks of gestation
Title
Number of admission for preterm labor
Description
Comparison of the number of admission for preterm labor from date of randomization until the date of the delivery between the 2 groups.
Time Frame
from date of randomization until the date of the delivery
Title
Number of fetal-neonatal death
Description
Number of fetal-neonatal death at delivery
Time Frame
at delivery
Title
Number of birth death
Description
Number of birth death at delivery until 6 weeks after the date of term
Time Frame
From date of delivery until 6 weeks after the date of term
Title
Number of patients with neonatal morbidity
Description
Number of patient with neonatal morbidity at delivery until 6 weeks after the date of term
Time Frame
From date of delivery until 6 weeks after the date of term
Title
Number of patients with increase of vaginal discharge
Description
Comparison of the number of patients with increase of vaginal discharge from date of randomization until the date of the delivery between the 2 groups of the study.
Time Frame
from date of randomization until the date of the delivery
Title
Number of patients with spontaneous pessary ejection
Description
Comparison of the number of patients with pessary ejection from date of randomization until the date of the delivery between the 2 groups of the study.
Time Frame
from date of randomization until the date of the delivery
Title
Number of patients with discomfort
Description
Comparison of the number of patients with discomfort from date of randomization until the date of the delivery between the 2 groups of the study. The discomfort is measure by a standardized questionnaire.
Time Frame
from date of randomization until the date of the delivery
Title
number of day between resolutive threatened preterm labor and delivery
Description
Comparison of number of day between the two groups of the study
Time Frame
At delivery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Minimal age of 18 years
Informed consent
Confirmation of dating of pregnancy by first trimester echography.
Episode of threatened preterm labour
Singleton between 24 and 34 weeks of gestation
Cervical length ≤20mm in cervimetry
Pulmonary maturation completed
≤6 contractions by hour after 24 hours of tocolysis.
Exclusion Criteria:
Major fetal abnormalities (requiring surgery or leading to infant death or severe handicap)
Spontaneous rupture of membranes at the time of randomization
Cervical cerclage in situ
Uterus malformations
Antecedent of conisation
Active vaginal bleeding, placenta previa
Intra-amniotic infection
Hydramnios
Maternal chronic pathology (hypertension, diabetes)
Anomaly of breathing foetal rate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Céline CHAULEUR, PhD
Organizational Affiliation
CHU SAINT-ETIENNE
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu Saint-Etienne
City
Saint-Etienne
ZIP/Postal Code
42055
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor
We'll reach out to this number within 24 hrs